[1] Itoh T, Hosokawa H, Kohdera U, et al. Disseminated infection with Trichosporon asahii[J]. Mycoses,1996, 39(5-6):195-199. [2] Thibeault R, Champagne M, de Repentigny L, et al. Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia[J]. Can J Infect Dis Med Microbiol, 2008, 19(2):203-205. [3] Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, et al. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1[J]. Diagn Microbiol Infect Dis,2007, 58(4):435-440. [4] Xia Z, Yang R, Wang W, et al. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients[J]. Mycopathologia,2011, 173(2-3):127-133. [5] Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities[J]. J Clin Microbiol,2001, 39(8):2971-2974. [6] Furlaneto-Maia L, Specian AF, Bizerra FC, et al. In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals[J]. Mycopathologia,2008, 166(4):209-217. [7] Negri M, Martins M, Henriques M, et al. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients[J]. Mycopathologia,2009, 169(3):175-182. [8] Di Bonaventura G, Pompilio A, Picciani C, et al. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance[J]. Antimicrob Agents Chemother,2006, 50(10):3269-3276. [9] Sugita T, Nakajima M, Ikeda R, et al. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species[J]. J Clin Microbiol,2002, 40(5):1826-1830. [10] Kalkanci A, Sugita T, Arikan S, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients[J]. Med Mycol,2010, 48(1):141-146. [11] Sugita T, Ichikawa T, Matsukura M, et al. Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersensitivity pneumonitis, and environmental materials[J]. J Clin Microbiol,2001, 39(7):2405-2411. [12] Guo LN, Xiao M, Kong F, et al. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China[J]. J Clin Microbiol, 2011, 49(11):3805-3811. [13] Chagas-Neto TC, Chaves GM, Melo AS, et al. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing[J]. J Clin Microbiol,2009, 47(4):1074-1081. [14] Tokimatsu I, Karashima R, Yamagata E, et al. Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis[J]. Nihon Ishinkin Gakkai Zasshi,2003, 44(3):181-186. |